KLK14
Basic information
Region (hg38): 19:51077495-51084245
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the KLK14 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 11 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 2 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 11 | 3 | 0 |
Variants in KLK14
This is a list of pathogenic ClinVar variants found in the KLK14 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-51078033-T-C | not specified | Uncertain significance (Jun 17, 2024) | ||
19-51078111-C-T | Male infertility | Uncertain significance (-) | ||
19-51078841-G-A | not specified | Uncertain significance (Sep 01, 2021) | ||
19-51078853-A-G | not specified | Uncertain significance (Dec 13, 2022) | ||
19-51078856-C-T | not specified | Uncertain significance (Jan 19, 2024) | ||
19-51078898-C-T | not specified | Uncertain significance (Nov 25, 2024) | ||
19-51078909-G-A | Likely benign (Jan 19, 2018) | |||
19-51079484-C-G | not specified | Uncertain significance (Aug 04, 2021) | ||
19-51079619-G-A | not specified | Uncertain significance (Feb 06, 2023) | ||
19-51079629-G-A | not specified | Uncertain significance (Apr 15, 2024) | ||
19-51079661-C-G | not specified | Uncertain significance (May 12, 2024) | ||
19-51079680-T-C | not specified | Uncertain significance (Apr 25, 2022) | ||
19-51081536-G-A | not specified | Uncertain significance (Aug 09, 2021) | ||
19-51081568-C-A | not specified | Uncertain significance (Jul 05, 2024) | ||
19-51081599-G-A | not specified | Uncertain significance (Mar 01, 2023) | ||
19-51081625-G-A | not specified | Likely benign (Jan 22, 2024) | ||
19-51081647-G-A | not specified | Uncertain significance (Mar 20, 2024) | ||
19-51082573-A-G | Uncertain significance (Oct 21, 2022) | |||
19-51082586-A-G | not specified | Uncertain significance (Jan 23, 2024) | ||
19-51082619-G-A | not specified | Uncertain significance (Sep 25, 2023) | ||
19-51082640-T-A | Likely benign (Jan 19, 2018) | |||
19-51082721-C-T | Likely benign (Jan 01, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
KLK14 | protein_coding | protein_coding | ENST00000391802 | 6 | 6751 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.00e-8 | 0.141 | 121314 | 55 | 3428 | 124797 | 0.0141 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.385 | 150 | 164 | 0.915 | 0.0000101 | 1681 |
Missense in Polyphen | 51 | 56.105 | 0.909 | 626 | ||
Synonymous | 1.22 | 58 | 71.1 | 0.816 | 0.00000483 | 554 |
Loss of Function | 0.0801 | 12 | 12.3 | 0.975 | 6.81e-7 | 119 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0141 | 0.0140 |
Ashkenazi Jewish | 0.00228 | 0.00229 |
East Asian | 0.000111 | 0.000111 |
Finnish | 0.00803 | 0.00796 |
European (Non-Finnish) | 0.0165 | 0.0164 |
Middle Eastern | 0.000111 | 0.000111 |
South Asian | 0.0333 | 0.0328 |
Other | 0.0107 | 0.0106 |
dbNSFP
Source:
- Function
- FUNCTION: Serine-type endopeptidase with a dual trypsin-like and chymotrypsin-like substrate specificity. May activate/inactivate the proteinase-activated receptors F2R, F2RL1 and F2RL3 and other kallikreins including KLK1, KLK3, KLK5 and KLK11. May function in seminal clot liquefaction through direct cleavage of the semenogelin SEMG1 and SEMG2 and activation of KLK3. May function through desmoglein DSG1 cleavage in epidermal desquamation a process by which the most superficial corneocytes are shed from the skin surface. May be involved in several aspects of tumor progression including growth, invasion and angiogenesis. {ECO:0000269|PubMed:15654974, ECO:0000269|PubMed:16885167, ECO:0000269|PubMed:17158887, ECO:0000269|PubMed:17625593, ECO:0000269|PubMed:18056261, ECO:0000269|PubMed:18482984}.;
- Pathway
- Keratinization;Developmental Biology;Formation of the cornified envelope
(Consensus)
Intolerance Scores
- loftool
- 0.343
- rvis_EVS
- 2.64
- rvis_percentile_EVS
- 98.81
Haploinsufficiency Scores
- pHI
- 0.0508
- hipred
- N
- hipred_score
- 0.146
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0664
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Klk14
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- proteolysis;fertilization;negative regulation of G protein-coupled receptor signaling pathway;positive regulation of G protein-coupled receptor signaling pathway;epidermis morphogenesis;cornification;seminal clot liquefaction
- Cellular component
- extracellular region;extracellular space;secretory granule
- Molecular function
- serine-type endopeptidase activity